Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paul G. Shiels is active.

Publication


Featured researches published by Paul G. Shiels.


Nature | 1999

Analysis of telomere lengths in cloned sheep

Paul G. Shiels; Alexander Kind; Keith H.S. Campbell; David Waddington; Ian Wilmut; Alan Colman; Angelika Schnieke

The development of nuclear-transfer techniques using cultured somatic cells allows animals to be produced without involving germline cells. This enables us to examine the importance of the repair of chromosome ends (telomeres) in the germ line and to test the telomere hypothesis of ageing.


Nature Genetics | 2010

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus

Timothy R. D. J. Radstake; Olga Y. Gorlova; Blanca Rueda; José Martín; Behrooz Z. Alizadeh; Rogelio Palomino-Morales; Marieke J. H. Coenen; Madelon C. Vonk; Alexandre E. Voskuyl; Annemie J. Schuerwegh; Jasper Broen; Piet L. C. M. van Riel; Ruben van 't Slot; Annet Italiaander; Roel A. Ophoff; Gabriela Riemekasten; Nico Hunzelmann; Carmen P. Simeon; Norberto Ortego-Centeno; Miguel A. González-Gay; María Francisca González-Escribano; Paolo Airò; Jaap van Laar; Ariane L. Herrick; Jane Worthington; Roger Hesselstrand; Vanessa Smith; Filip De Keyser; F. Houssiau; Meng May Chee

Systemic sclerosis (SSc) is an autoimmune disease characterized by fibrosis of the skin and internal organs that leads to profound disability and premature death. To identify new SSc susceptibility loci, we conducted the first genome-wide association study in a population of European ancestry including a total of 2,296 individuals with SSc and 5,171 controls. Analysis of 279,621 autosomal SNPs followed by replication testing in an independent case-control set of European ancestry (2,753 individuals with SSc (cases) and 4,569 controls) identified a new susceptibility locus for systemic sclerosis at CD247 (1q22–23, rs2056626, P = 2.09 × 10−7 in the discovery samples, P = 3.39 × 10−9 in the combined analysis). Additionally, we confirm and firmly establish the role of the MHC (P = 2.31 × 10−18), IRF5 (P = 1.86 × 10−13) and STAT4 (P = 3.37 × 10−9) gene regions as SSc genetic risk factors.


British Journal of Cancer | 2006

Altered sirtuin expression is associated with node-positive breast cancer

N. Ashraf; Alan MacIntyre; David Kingsmore; Anthony P. Payne; W.D. George; Paul G. Shiels

Sirtuins are genes implicated in cellular and organismal ageing. Consequently, they are speculated to be involved in diseases of ageing including cancer. Various cancers with widely differing prognosis have been shown to have differing and characteristic expression of these genes; however, the relationship between sirtuin expression and cancer progression is unclear. In order to correlate cancer progression and sirtuin expression, we have assessed sirtuin expression as a function of primary cell ageing and compared sirtuin expression in normal, ‘nonmalignant’ breast biopsies to breast cancer biopsies using real-time polymerase chain reaction (PCR). Levels of SIRT7 expression were significantly increased in breast cancer (P<0.0001). Increased levels of SIRT3 and SIRT7 transcription were also associated with node-positive breast cancer (P<0.05 and P<0.0001, respectively). This study has demonstrated differential sirtuin expression between nonmalignant and malignant breast tissue, with consequent diagnostic and therapeutic implications.


Experimental Gerontology | 2014

Gender and telomere length: Systematic review and meta-analysis

Michael P. Gardner; David Bann; Laura Wiley; Rachel Cooper; Rebecca Hardy; Dorothea Nitsch; Carmen Martin-Ruiz; Paul G. Shiels; Avan Aihie Sayer; Michelangela Barbieri; Sofie Bekaert; Claus Bischoff; Angela Brooks-Wilson; Wei Chen; C Cooper; Kaare Christensen; Tim de Meyer; Ian J. Deary; Geoff Der; Ana V. Diez Roux; Annette L. Fitzpatrick; Anjum Hajat; Julius Halaschek-Wiener; Sarah E. Harris; Steven C. Hunt; Carol Jagger; Hyo Sung Jeon; Robert C. Kaplan; Masayuki Kimura; Peter M. Lansdorp

BACKGROUND It is widely believed that females have longer telomeres than males, although results from studies have been contradictory. METHODS We carried out a systematic review and meta-analyses to test the hypothesis that in humans, females have longer telomeres than males and that this association becomes stronger with increasing age. Searches were conducted in EMBASE and MEDLINE (by November 2009) and additional datasets were obtained from study investigators. Eligible observational studies measured telomeres for both females and males of any age, had a minimum sample size of 100 and included participants not part of a diseased group. We calculated summary estimates using random-effects meta-analyses. Heterogeneity between studies was investigated using sub-group analysis and meta-regression. RESULTS Meta-analyses from 36 cohorts (36,230 participants) showed that on average females had longer telomeres than males (standardised difference in telomere length between females and males 0.090, 95% CI 0.015, 0.166; age-adjusted). There was little evidence that these associations varied by age group (p=1.00) or cell type (p=0.29). However, the size of this difference did vary by measurement methods, with only Southern blot but neither real-time PCR nor Flow-FISH showing a significant difference. This difference was not associated with random measurement error. CONCLUSIONS Telomere length is longer in females than males, although this difference was not universally found in studies that did not use Southern blot methods. Further research on explanations for the methodological differences is required.


Neuroscience Letters | 2006

The association between telomere length, physical health, cognitive ageing, and mortality in non-demented older people

Sarah E. Harris; Ian J. Deary; Alan MacIntyre; K. Lamb; Kamaraj Radhakrishnan; Lawrence J. Whalley; Paul G. Shiels

Telomeres are nucleo-protein complexes that protect the ends of chromosomes. The telomeric DNA component shortens each time a somatic cell replicates, eventually leading to cell senescence. Telomere length has been associated with morbidity and mortality rates from age-related diseases. We tested the hypotheses that mean peripheral blood leukocyte telomere length, at age 79 years, is associated with physical health at age 79, cognitive ability at age 79, lifetime cognitive change, smoking, alcohol consumption, social class in adulthood, and mortality in a cohort of people without dementia (the Lothian Birth Cohort 1921: LBC1921). There was a small, significant association between telomere length and verbal fluency (a test of executive function) before (r=-0.16, p=0.027) and after (r=-0.17, p=0.022) adjustment for mental ability at age 11. This might be a type 1 error. Otherwise, we find that telomere length in old age does not have a significant association with age-related physical and cognitive decline or mortality.


PLOS Genetics | 2011

Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy

Olga Y. Gorlova; José Martín; Blanca Rueda; Bobby P. C. Koeleman; Jun Ying; María Teruel; Lina Marcela Diaz-Gallo; Jasper Broen; Madelon C. Vonk; Carmen P. Simeon; Behrooz Z. Alizadeh; Marieke J. H. Coenen; Alexandre E. Voskuyl; Annemie J. Schuerwegh; Piet L. C. M. van Riel; Marie Vanthuyne; Ruben van 't Slot; Annet Italiaander; Roel A. Ophoff; Nicolas Hunzelmann; Vicente Fonollosa; Norberto Ortego-Centeno; Miguel A. González-Gay; Francisco J. García-Hernández; María F. González-EscribanoMarí; Paolo Airò; Jacob M van Laar; Jane Worthington; Roger Hesselstrand; Vanessa Smith

The aim of this study was to determine, through a genome-wide association study (GWAS), the genetic components contributing to different clinical sub-phenotypes of systemic sclerosis (SSc). We considered limited (lcSSc) and diffuse (dcSSc) cutaneous involvement, and the relationships with presence of the SSc-specific auto-antibodies, anti-centromere (ACA), and anti-topoisomerase I (ATA). Four GWAS cohorts, comprising 2,296 SSc patients and 5,171 healthy controls, were meta-analyzed looking for associations in the selected subgroups. Eighteen polymorphisms were further tested in nine independent cohorts comprising an additional 3,175 SSc patients and 4,971 controls. Conditional analysis for associated SNPs in the HLA region was performed to explore their independent association in antibody subgroups. Overall analysis showed that non-HLA polymorphism rs11642873 in IRF8 gene to be associated at GWAS level with lcSSc (P = 2.32×10−12, OR = 0.75). Also, rs12540874 in GRB10 gene (P = 1.27 × 10−6, OR = 1.15) and rs11047102 in SOX5 gene (P = 1.39×10−7, OR = 1.36) showed a suggestive association with lcSSc and ACA subgroups respectively. In the HLA region, we observed highly associated allelic combinations in the HLA-DQB1 locus with ACA (P = 1.79×10−61, OR = 2.48), in the HLA-DPA1/B1 loci with ATA (P = 4.57×10−76, OR = 8.84), and in NOTCH4 with ACA P = 8.84×10−21, OR = 0.55) and ATA (P = 1.14×10−8, OR = 0.54). We have identified three new non-HLA genes (IRF8, GRB10, and SOX5) associated with SSc clinical and auto-antibody subgroups. Within the HLA region, HLA-DQB1, HLA-DPA1/B1, and NOTCH4 associations with SSc are likely confined to specific auto-antibodies. These data emphasize the differential genetic components of subphenotypes of SSc.


Journal of Internal Medicine | 2008

Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.

Juan Jesus Carrero; Peter Stenvinkel; Bengt Fellström; Abdul Rashid Qureshi; K. Lamb; Olof Heimbürger; Peter Bárány; Kamaraj Radhakrishnan; Bengt Lindholm; Inga Soveri; Louise Nordfors; Paul G. Shiels

Introduction.  Chronic kidney disease (CKD) predisposes to a 10‐ to 20‐fold increased cardiovascular risk. Patients undergo accelerated atherogenesis and vascular ageing. We investigated whether telomere attrition, a marker of cell senescence, contributes to this increased mortality risk.


International Journal of Epidemiology | 2012

Socio-economic status is associated with epigenetic differences in the pSoBid cohort

Dagmara McGuinness; Liane McGlynn; Paul Johnson; Alan MacIntyre; G. D. Batty; Harry Burns; Jonathan Cavanagh; Kevin A. Deans; Ian Ford; Alex McConnachie; Agnes McGinty; Jennifer S. McLean; Keith Millar; Christopher J. Packard; Naveed Sattar; Carol Tannahill; Yoga N. Velupillai; Paul G. Shiels

BACKGROUND Epigenetic programming and epigenetic mechanisms driven by environmental factors are thought to play an important role in human health and ageing. Global DNA methylation has been postulated as an epigenetic marker for epidemiological studies as it is reflective of changes in gene expression linked to disease. How epigenetic mechanisms are affected by psychological, sociological and biological determinants of health still remains unclear. The aim of this study was to investigate the relationship between socio-economic and lifestyle factors and epigenetic status, as measured by global DNA methylation content, in the pSoBid cohort, which is characterized by an extreme socio-economic and health gradient. METHODS DNA was extracted from peripheral blood leukocytes using the Maxwell® 16 System and Maxwell® 16 Blood DNA Purification kit (Promega, UK). Global DNA methylation was assessed using Methylamp™ Global DNA Methylation Quantification Ultra kit (Epigentek, USA). Associations between global DNA methylation and socio-economic and lifestyle factors were investigated in linear regression models. RESULTS Global DNA hypomethylation was observed in the most socio-economically deprived subjects. Job status demonstrated a similar relationship, with manual workers having 24% lower DNA methylation content than non-manual. Additionally, associations were found between global DNA methylation content and biomarkers of cardiovascular disease (CVD) and inflammation, including fibrinogen and interleukin-6 (IL-6), after adjustment for socio-economic factors. CONCLUSIONS This study has indicated an association between epigenetic status and socio-economic status (SES). This relationship has direct implications for population health and is reflected in further associations between global DNA methylation content and emerging biomarkers of CVD.


American Journal of Human Genetics | 2014

Immunochip Analysis Identifies Multiple Susceptibility Loci for Systemic Sclerosis

Maureen D. Mayes; Lara Bossini-Castillo; Olga Y. Gorlova; José Martín; Xiaodong Zhou; Wei Chen; Shervin Assassi; Jun Ying; Filemon K. Tan; Frank C. Arnett; John D. Reveille; Sandra G. Guerra; María Teruel; F. Carmona; Peter K. Gregersen; Annette Lee; Elena López-Isac; Eguzkine Ochoa; Patricia Carreira; Carmen P. Simeon; I. Castellví; Miguel A. González-Gay; Alexandra Zhernakova; Leonid Padyukov; Marta E. Alarcón-Riquelme; Cisca Wijmenga; Matthew A. Brown; Lorenzo Beretta; Gabriela Riemekasten; Torsten Witte

In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human leukocyte antigen (HLA) region were imputed and tested. These analyses resulted in a model composed of six polymorphic amino acid positions and seven SNPs that explained the observed significant associations in the region. In addition, a replication step comprising 4,017 SSc cases and 5,935 controls was carried out for several selected non-HLA variants, reaching a total of 5,850 cases and 9,401 controls of European ancestry. Following this strategy, we identified and validated three SSc risk loci, including DNASE1L3 at 3p14, the SCHIP1-IL12A locus at 3q25, and ATG5 at 6q21, as well as a suggested association of the TREH-DDX6 locus at 11q23. The associations of several previously reported SSc risk loci were validated and further refined, and the observed peak of association in PXK was related to DNASE1L3. Our study has increased the number of known genetic associations with SSc, provided further insight into the pleiotropic effects of shared autoimmune risk factors, and highlighted the power of dense mapping for detecting previously overlooked susceptibility loci.


International Journal of Epidemiology | 2015

Reproducibility of telomere length assessment: an international collaborative study.

Carmen Martin-Ruiz; Duncan Martin Baird; Laureline Roger; Petra Boukamp; Damir Krunic; Richard M. Cawthon; Martin M Dokter; Pim van der Harst; Sofie Bekaert; Tim de Meyer; Göran Roos; Ulrika Svenson; Veryan Codd; Nilesh J. Samani; Liane McGlynn; Paul G. Shiels; Karen A. Pooley; Alison M. Dunning; Rachel Cooper; Andrew Wong; Andrew Kingston; Thomas von Zglinicki

Background: Telomere length is a putative biomarker of ageing, morbidity and mortality. Its application is hampered by lack of widely applicable reference ranges and uncertainty regarding the present limits of measurement reproducibility within and between laboratories. Methods: We instigated an international collaborative study of telomere length assessment: 10 different laboratories, employing 3 different techniques [Southern blotting, single telomere length analysis (STELA) and real-time quantitative PCR (qPCR)] performed two rounds of fully blinded measurements on 10 human DNA samples per round to enable unbiased assessment of intra- and inter-batch variation between laboratories and techniques. Results: Absolute results from different laboratories differed widely and could thus not be compared directly, but rankings of relative telomere lengths were highly correlated (correlation coefficients of 0.63–0.99). Intra-technique correlations were similar for Southern blotting and qPCR and were stronger than inter-technique ones. However, inter-laboratory coefficients of variation (CVs) averaged about 10% for Southern blotting and STELA and more than 20% for qPCR. This difference was compensated for by a higher dynamic range for the qPCR method as shown by equal variance after z-scoring. Technical variation per laboratory, measured as median of intra- and inter-batch CVs, ranged from 1.4% to 9.5%, with differences between laboratories only marginally significant (P = 0.06). Gel-based and PCR-based techniques were not different in accuracy. Conclusions: Intra- and inter-laboratory technical variation severely limits the usefulness of data pooling and excludes sharing of reference ranges between laboratories. We propose to establish a common set of physical telomere length standards to improve comparability of telomere length estimates between laboratories.

Collaboration


Dive into the Paul G. Shiels's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carmen P. Simeon

Autonomous University of Barcelona

View shared research outputs
Top Co-Authors

Avatar

Madelon C. Vonk

Radboud University Nijmegen

View shared research outputs
Top Co-Authors

Avatar

Annemie J. Schuerwegh

Leiden University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexandre E. Voskuyl

VU University Medical Center

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge